Acclinate

Acclinate is a Birmingham, Alabama-based digital health company that combines cutting-edge technology with grassroots community engagement to connect, educate, and empower underrepresented communities in clinical research. Founded in 2020 by Del Smith and Tiffany Whitlow, Acclinate addresses the systemic lack of diversity in pharmaceutical clinical trials through its flagship NOWINCLUDED community platform, which has grown to over 250,000 members nationwide. The company's patented AI/ML engine, e-DICT (Enhanced Diversity in Clinical Trials), uses predictive analytics and machine learning to identify individuals most likely to be receptive to participation in a particular clinical trial, powered by Google Cloud's Vertex AI. Acclinate serves 7 of the top 10 global pharmaceutical companies, partnering with organizations including Merck and Cencora Ventures. The company has been recognized on the Inc. 5000 list of fastest-growing private companies and has raised $7 million in Series A funding.